Journal of Psychiatry and Neurochemistry Research

Aim & Scope

The Journal of Psychiatry and Neurochemistry Research (ISSN: 3065-4874) is established to serve as a scholarly forum for high-quality research that explores the intricate links between psychiatric disorders and neurochemical processes. The journal’s central aim is to deepen the scientific and clinical understanding of mental illnesses by emphasizing the role of neurochemical signaling, neurotransmitter pathways, and molecular mechanisms in shaping human cognition, behavior, and emotional regulation.

We are committed to publishing peer-reviewed contributions that reflect both experimental rigor and clinical relevance. The journal addresses a growing need for interdisciplinary research that spans psychiatry, neurochemistry, psychopharmacology, molecular biology, and neurobiology, and it welcomes studies that bridge the gap between laboratory investigations and clinical applications.

Interdisciplinary Focus

This journal is designed to be a meeting ground for a wide range of scientific disciplines that collectively advance our understanding of the biological basis of psychiatric conditions. The scope includes, but is not limited to:

• Neurotransmitter Systems: Research on dopamine, serotonin, norepinephrine, and other neurotransmitters in conditions such as depression, anxiety, schizophrenia, bipolar disorder, and obsessive-compulsive disorder.
• Neurochemical Mechanisms of Psychotropic Medications: Studies analyzing how medications affect synaptic transmission, receptor function, and neural plasticity in psychiatric populations.
• Molecular and Cellular Psychiatry: Investigations into intracellular signaling pathways, genetic markers, and epigenetic modifications relevant to mental health disorders.
• Neuroimmunology and Inflammation: Exploration of the role of inflammatory cytokines and immune system dysregulation in psychiatric pathophysiology.
• Neurodevelopment and Neurodegeneration: Research that connects neurochemical changes to developmental disorders such as autism spectrum disorder or age-related diseases like dementia.
• Stress, HPA Axis, and Hormonal Interactions: Studies that examine how stress and hormonal imbalance impact mood and psychiatric function through neurochemical pathways.
• Substance Use and Addiction Neurochemistry: Articles focused on how various substances alter neurochemical processes and influence psychiatric comorbidity.
• Neuroimaging and Biomarker Identification: Studies using techniques like fMRI, PET, and MR spectroscopy to visualize and quantify neurochemical changes.

Publication Objectives

The journal aims to:

• Disseminate original research that enhances our understanding of how neurochemistry influences psychiatric conditions
• Encourage collaboration between basic scientists and clinical practitioners in psychiatry
• Promote innovative treatments and therapeutic approaches grounded in molecular and chemical neuroscience
• Advance the field of psychopharmacology by exploring novel compounds and their mechanisms of action
• Provide a platform for early-stage and emerging researchers to share significant data and insights

Scope of Articles Accepted

The journal welcomes various types of submissions that fall within its thematic focus:

• Original Research Articles presenting clinical trials, molecular investigations, and neurochemical experiments
• Systematic Reviews and Meta-Analyses summarizing available literature on defined neuropsychiatric topics
• Narrative Reviews offering expert perspectives and thematic syntheses
• Case Studies describing neurochemical anomalies and psychiatric presentations in unique clinical settings
• Brief Reports and Technical Notes introducing new research methods, diagnostic approaches, or preliminary findings

This journal does not restrict itself to one school of thought or methodological orientation. Instead, it promotes scientific pluralism and encourages the submission of work that reflects diverse paradigms and international research standards.

Relevance to the Global Mental Health Community

By focusing on the biochemical substrates of psychiatric disorders, the journal contributes to a growing global awareness of the need for biologically informed mental health care. The research published here informs drug development, diagnostic innovation, clinical decision-making, and public health policy.

The Journal of Psychiatry and Neurochemistry Research aims to be a critical resource for professionals who seek a deeper understanding of how brain chemistry interacts with mental health and illness. Whether addressing pharmacological mechanisms or decoding molecular biomarkers, the journal remains committed to scientific excellence and clinical applicability.

Author Guidelines

The Journal of Psychiatry and Neurochemistry Research (ISSN: 3065-4874) invites researchers, clinicians, and academicians to submit original, high-quality manuscripts that contribute to the fields of psychiatry, neurochemistry, molecular neuroscience, psychopharmacology, neurobiology, and related disciplines. This guide provides comprehensive instructions to facilitate the submission, review, and publication process. Authors are encouraged to read the guidelines thoroughly before submitting their work.

1. Types of Manuscripts Accepted

We welcome submissions in the following formats:

• Original Research Articles: Empirical studies involving clinical trials, neurochemical assays, molecular or cellular investigations, and translational psychiatry research.
• Review Articles: Detailed and evidence-based overviews of specific topics, offering a critical synthesis of existing literature in psychiatry and neurochemistry.
• Short Communications: Brief reports that highlight novel findings or early-stage research that is of immediate relevance.
• Case Reports: Detailed analyses of individual clinical cases involving unique neurochemical findings or treatment responses.
• Technical Notes: Descriptions of innovative techniques, experimental protocols, or analytic methods.
• Letters to the Editor: Commentary, critique, or additional insights related to articles previously published in the journal.

Each manuscript type must adhere to specific structural and formatting requirements, as outlined below.

2. Manuscript Formatting and Structure

All submissions must be in clear, grammatically correct English. Manuscripts must be formatted as follows:

• Title Page: Include the full title, names of all authors, institutional affiliations, and corresponding author's contact information.
• Abstract: A structured abstract of no more than 300 words summarizing the background, objectives, methods, results, and conclusions. Use relevant keywords.
• Keywords: A list of 5 to 8 keywords that reflect the core themes of the study, such as neurotransmitters, neuroinflammation, psychiatric disorders, synaptic plasticity, molecular markers, neuroimaging, psychotropic agents.
• Main Text:

- Introduction: Establish the context and rationale behind the research.

- Materials and Methods: Clearly describe study design, patient or sample selection, procedures, and analytical techniques. Ensure reproducibility.

- Results: Present findings objectively with appropriate use of tables, graphs, and statistical indicators.

- Discussion: Interpret the results, connect them with existing literature, and identify clinical or research implications.

- Conclusion: Summarize key findings and potential applications.

• Acknowledgments: Disclose funding sources, contributions of non-authors, and institutional support.
• Conflict of Interest Statement: Authors must declare any financial or personal relationships that could influence the research.
• References: Follow a consistent citation format (e.g., Vancouver or APA). References must be current and relevant.

3. Submission Procedure

Authors must submit manuscripts through the journal’s official online submission system or via the designated editorial email address. Files must be in .doc or .docx format. Figures should be submitted as separate high-resolution image files (JPEG, PNG, or TIFF).

Each submission must be accompanied by:

• A cover letter stating the originality of the work, its relevance to the journal, and that it is not under consideration elsewhere.
• A statement of ethical compliance confirming that research involving human or animal subjects complies with institutional and international ethical standards.

Manuscripts undergo a double-blind peer review process. Authors must ensure that identifying information is removed from the main text and file metadata to maintain reviewer anonymity.

4. Peer Review and Editorial Process

Upon submission, manuscripts are screened for compliance with journal guidelines and ethical standards. Suitable submissions are assigned to independent peer reviewers with expertise in relevant domains such as neurochemistry, psychiatric disorders, psychopharmacology, and translational neuroscience.

The review process involves:

• Initial editorial assessment
• Double-blind peer review by at least two experts
• Editorial decision (accept, revise, or reject) based on reviewer feedback

Revised manuscripts must be submitted within the specified timeframe, addressing all reviewer comments systematically.

5. Ethical Considerations

• Human Subjects Research: Manuscripts involving patients or human participants must include a statement of ethical approval by an institutional review board and written informed consent from all subjects.
• Animal Studies: Research involving animals must follow internationally accepted standards for the humane treatment of animals and include an ethics approval statement.
• Plagiarism and Misconduct: The journal maintains zero tolerance for plagiarism, falsified data, duplicate publication, or unethical research conduct. All submissions are screened using plagiarism detection software.
• Authorship Criteria: Only individuals who have made substantial contributions to the conception, design, execution, or interpretation of the study should be listed as authors.

6. Article Processing Charges

The Journal of Psychiatry and Neurochemistry Research operates under an open-access model to ensure free and immediate access to scholarly content for the global scientific and clinical community. Authors are responsible for paying an article processing charge upon acceptance of the manuscript. The APC helps support peer review, digital archiving, indexing, and long-term accessibility of published research.

Exact APC details are available upon request or during the final stages of acceptance.

7. Open Access and Copyright

All articles published in this journal are made freely available under a Creative Commons license. Authors retain full copyright of their work. The journal supports the widest possible dissemination of research and encourages sharing, reproduction, and educational reuse, provided proper attribution is given.

8. Contact Information

For manuscript submissions, editorial queries, or technical support, authors may contact the editorial office via the journal’s website or by email. A response will typically be provided within 3–5 working days.

Editorial Board

María-José Martín-Vázquez

Editor-in-Chief
Assistant Professor, Community Mental Health Service Sofia Hospital, Spain

Dr. Giuseppe Iurato

Associate Editor
Linnaeus University, Vaxjo, Sweden

Michel BOURIN

Professor of Pharmacology, University of Nantes, France

Seyyed Ali Hosseini

Translational Neuroimaging Laboratory, Department of Neurology & Neurosurgery, McGill University,Canada

Sam Vaknin

Former Visiting Professor of Psychology, Southern Federal University, Rostov-on-Don, Russia

Dr. Sinisa Franjic

Independent Researcher, Europe

Dr. Shao-Wen Hung,

Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan

Hongfei Li

Department of Statistics, University of Connecticut, Storrs, CT, United States

Abdul Rehman M. Qureshi

Parkinson’s Clinic of Eastern Toronto & Movement Disorders Centre, Toronto, Ontario, M1B 4Z8, Canada

Monish Sheth, MD, FHM

Clinical Associate Professor of Medicine, Texas A&M University, USA

Dr. Yury Evgeny Razvodovsky

Professor of Psychiatry International Academy of Sobriety Belarus, Russia

Jovana Cvetkovic

Clinical Hospital Center Gracanica, Serbia

Articles In Press

Current Issue

Archive

Presentations

Indexing